Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludovica Ganino

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Medicine|August 28, 2023
Lipid metabolic vulnerabilities of multiple myelomaRoberta Torcasio, Maria Eugenia Gallo Cantafio, Raissa Kaori Ikeda, et al.
Antioxidants (Basel, Switzerland)|January 28, 2026
OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug DevelopmentAntonio Curcio, Ludovica Ganino, Ilenia Valentino, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|December 8, 2025
Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistanceTeresa Rossi, Roberta Torcasio, Ludovica Ganino, et al.
Cancers|March 28, 2026
Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic OpportunitiesFrancesco Caprino, Ilenia Valentino, Antonella Bruzzese, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional StudyDavide Bolignano, Marta Greco, Mario D'Agostino, et al.
Antioxidants (Basel, Switzerland)|November 27, 2024
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics SimulationsAntonio Curcio, Roberta Rocca, Federica Chiera, et al.
Journal of Translational Medicine|August 15, 2025
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclaxIlenia Valentino, Maria Eugenia Gallo Cantafio, Roberta Torcasio, et al.
Journal of Translational Medicine|February 27, 2024
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activityRoberta Torcasio, Maria Eugenia Gallo Cantafio, Claudia Veneziano, et al.
Haematologica|May 22, 2025
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myelomaMaria Eugenia Gallo Cantafio, Ilenia Valentino, Roberta Torcasio, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Medicine|August 28, 2023
Lipid metabolic vulnerabilities of multiple myelomaRoberta Torcasio, Maria Eugenia Gallo Cantafio, Raissa Kaori Ikeda, et al.
Antioxidants (Basel, Switzerland)|January 28, 2026
OPA1 as a Cancer Target: Molecular Mechanisms, Structural Insights, and Strategies for Drug DevelopmentAntonio Curcio, Ludovica Ganino, Ilenia Valentino, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|December 8, 2025
Dysregulated mitochondrial dynamics in cancer: Unlocking new strategies to combat drug resistanceTeresa Rossi, Roberta Torcasio, Ludovica Ganino, et al.
Cancers|March 28, 2026
Targeting Mitochondrial Vulnerabilities in Chronic Myeloid Leukemia: From Pathobiology to Novel Therapeutic OpportunitiesFrancesco Caprino, Ilenia Valentino, Antonella Bruzzese, et al.
Medicina (Kaunas, Lithuania)|August 26, 2023
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional StudyDavide Bolignano, Marta Greco, Mario D'Agostino, et al.
Antioxidants (Basel, Switzerland)|November 27, 2024
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics SimulationsAntonio Curcio, Roberta Rocca, Federica Chiera, et al.
Journal of Translational Medicine|August 15, 2025
Targeting the MARCH5-MFN2 axis to enhance mitochondrial fusion and sensitize multiple myeloma cells to venetoclaxIlenia Valentino, Maria Eugenia Gallo Cantafio, Roberta Torcasio, et al.
Journal of Translational Medicine|February 27, 2024
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activityRoberta Torcasio, Maria Eugenia Gallo Cantafio, Claudia Veneziano, et al.
Haematologica|May 22, 2025
Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myelomaMaria Eugenia Gallo Cantafio, Ilenia Valentino, Roberta Torcasio, et al.
Pageof 1